Tivozanib

FDA Drug Profile — FOTIVDA

Drug Details

Generic Name
Tivozanib
Brand Names
FOTIVDA
Application Number
NDA212904
Sponsor
Catalent Pharma Solution, LLC
NDC Codes
6
Dosage Forms
CAPSULE
Routes
ORAL
Active Ingredients
TIVOZANIB HYDROCHLORIDE

Indications and Usage

1 INDICATIONS AND USAGE FOTIVDA is indicated for the treatment of adult patients with relapsed or refractory advanced renal cell carcinoma (RCC) following two or more prior systemic therapies. FOTIVDA is a kinase inhibitor indicated for the treatment of adult patients with relapsed or refractory advanced renal cell carcinoma (RCC) following two or more prior systemic therapies. ( 1 )